| 1. |
Wang FS, Fan JG, Zhang Z, et al. The global burden of liver disease: the major impact of China. Hepatology, 2014, 60(6): 2099-2108.
|
| 2. |
Shindoh J, Hasegawa K, Inoue Y, et al. Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma. HPB (Oxford), 2013, 15(1): 31-39.
|
| 3. |
陈星, 李强, 荀晓冬, 等. 微血管侵犯对单发小肝癌患者术后无进展生存期的影响. 中华肝胆外科杂志, 2016, 22(2): 94-98.
|
| 4. |
中国抗癌协会肝癌专业委员会, 中华医学会肝病学分会肝癌学组, 中国抗癌协会病理专业委员, 等. 原发性肝癌规范化病理诊断指南(2015年版). 中华肝脏病杂志, 2015, 23(5): 321-327.
|
| 5. |
Parfitt JR, Marotta P, Alghamdi M, et al. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl, 2007, 13(4): 543-551.
|
| 6. |
Strilic B, Yang L, Albarrán-Juárez J, et al. Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis. Nature, 2016, 536(7615): 215-218.
|
| 7. |
Lei Z, Li J, Wu D, et al. Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria. JAMA Surg, 2016, 151(4): 356-363.
|
| 8. |
Rodríguez-Perálvarez M, Luong TV, Andreana L, et al. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol, 2013, 20(1): 325-339.
|
| 9. |
冯龙海, 丛文铭. 肝细胞癌微血管侵犯新型分级系统的建立及其临床病理学意义的研究. 第二军医大学, 2016.
|
| 10. |
Iguchi T, Shirabe K, Aishima S, et al. New pathologic stratification of microvascular invasion in hepatocellular carcinoma: predicting prognosis after living-donor liver transplantation. Transplantation, 2015, 99(6): 1236-1242.
|
| 11. |
Zhou Y, Xu D, Wu L, et al. Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Langenbecks Arch Surg, 2011, 396(7): 1109-1117.
|
| 12. |
雷正清, 沈锋. 早期肝癌微血管侵犯的术前预测和对肝切除切缘选择的影响. 第二军医大学, 2016.
|
| 13. |
Minami Y, Nishida N, Kudo M. Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI. World J Gastroenterol, 2014, 20(15): 4160-4166.
|
| 14. |
刘学, 沈锋. MVI作为肝细胞癌术后辅助性TACE治疗指征的研究. 第二军医大学, 2012.
|
| 15. |
Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase Ⅲ randomised, double-blind, placebo-controlled trial. Lancet Oncol, 2009, 10(1): 25-34.
|
| 16. |
Banerjee S, Wang DS, Kim HJ, et al. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology, 2015, 62(3): 792-800.
|
| 17. |
Kobayashi T, Aikata H, Honda F, et al. Preoperative fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for prediction of microvascular invasion in small hepatocellular carcinoma. J Comput Assist Tomogr, 2016, 40(4): 524-530.
|
| 18. |
李文柱, 苏丹柯. 能谱CT预测肝细胞癌微血管侵犯的可能性研究. 广西医科大学, 2016.
|
| 19. |
Renzulli M, Brocchi S, Cucchetti A, et al. Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma? Radiology, 2016, 279(2): 432-442.
|
| 20. |
Han MA, Lee DH, Woo SM, et al. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells. Sci Rep, 2016, 6: 18642.
|
| 21. |
Shirabe K, Kajiyama K, Abe T, et al. Predictors of microscopic portal vein invasion by hepatocellular carcinoma: measurement of portal perfusion defect area ratio. J Gastroenterol Hepatol, 2009, 24(8): 1431-1436.
|
| 22. |
Xu P, Zeng M, Liu K, et al. Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging? J Gastroenterol Hepatol, 2014, 29(2): 330-336.
|
| 23. |
Min JH, Kim YK, Lim S, et al. Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: Impact of intra-tumoral fat detected on chemical-shift images. Eur J Radiol, 2015, 84(6): 1036-1043.
|
| 24. |
贾丛丛, 周玮, 何国浓. 原发性肝癌彩色多普勒超声血流分级与微血管生成的关系. 中国现代医生, 2016, 54(9): 103-105, 109, 封3.
|
| 25. |
You Z, Chen LP, Ye H. Predictors of microvascular invasion in patients with solitary small hepatitis B related hepatocellular carcinoma. Pak J Med Sci, 2014, 30(2): 331-334.
|
| 26. |
Imura S, Teraoku H, Yoshikawa M, et al. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria. Int J Clin Oncol, 2018, 23(1): 98-103.
|
| 27. |
Poté N, Cauchy F, Albuquerque M, et al. Performance of PIVKA-Ⅱ for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion. J Hepatol, 2015, 62(4): 848-854.
|
| 28. |
Poon RT, Ng IO, Lau C, et al. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg, 2001, 233(2): 227-235.
|
| 29. |
Zhu PP, Yuan SG, Liao Y, et al. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma. World J Gastroenterol, 2015, 21(23): 7254-7263.
|
| 30. |
汪宇, 李锡锋, 张小峰, 等. 术前外周血循环肿瘤细胞检测对原发性肝细胞肝癌微血管侵犯的预测价值. 山东医药, 2017, 57(18): 33-35.
|
| 31. |
Liu M, Wang L, Zhu H, et al. A preoperative measurement of serum microRNA-125b may predict the presence of microvascular invasion in hepatocellular carcinomas patients. Transl Oncol, 2016, 9(3): 167-172.
|
| 32. |
Enooku K, Uranbileg B, Ikeda H, et al. Higher LPA2 and LPA6 mRNA levels in hepatocellular carcinoma are associated with poorer differentiation, microvascular invasion and earlier recurrence with higher serum autotaxin levels. PLoS One, 2016, 11(9): e0161825.
|
| 33. |
Zhuang LP, Meng ZQ. Serum miR-224 reflects stage of hepatocellular carcinoma and predicts survival. Biomed Res Int, 2015, 2015: 731781.
|
| 34. |
Yoon EL, Yeon JE, Ko E, et al. Significance of serum miR-10b-3p in predicting presence of microvascular invasion of hepatocellular carcinoma. Hepatol, 2014, 60(1): 85-86.
|
| 35. |
Meng FL, Wang W, Jia WD. Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma. Med Oncol, 2014, 31(9): 177.
|
| 36. |
毛毳, 吴建军, 王建新, 等. 乙肝病毒感染状态与乙肝相关肝细胞癌微血管侵犯形成的关系. 交通医学, 2017, 31(5): 455-457, 460.
|
| 37. |
Huang C, Wang Y, Liu S, et al. Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvascular invasion in hepatocellular carcinoma. J Proteome Res, 2013, 12(4): 1838-1846.
|
| 38. |
赵伟, 刘文广, 刘华平, 等. 肝癌微血管密度、微血管面积和Piezo1的表达与微血管侵犯的相关性. 临床与病理杂志, 2017, 37(8): 1593-1600.
|
| 39. |
赵晖, 仇毓东. 肝细胞癌微血管侵犯的预后评估及术前预测模型的建立. 南京医科大学, 2018.
|
1/5
WeChat